Characterising the molecular pathogenesis of newly emergent invasive group A Streptococcus M4 serotypes in Australia

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1033258

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Group A Streptococcus (GAS) is a human pathogen of global significance, responsible for life-threatening invasive infections such as flesh-eating disease (>650,000 cases per year), with a mortality rate of 25%. A recent outbreak of serotype M4 GAS caused severe invasive infections in Queensland Australia. The aim of this work is to determine how M4 GAS causes invasive disease. Understanding this mechanism will allow the development of new generation therapeutics, treatments and improved health outcomes.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2015

Funding Scheme: Project Grants

Funding Amount: $523,756.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical Microbiology not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Streptococcus pyogenes | bacterial pathogenesis | group A streptococcal disease | host/pathogen interaction | infectious diseases | innate immunity | necrotising fasciitis | streptococcal disease | streptococcal infection | streptococcal invasive diseases

Related Links